Differential regulation of systemic il-18 and il-12 release during postoperative sepsis: High serum il-18 as an early predictive indicator of lethal outcome

Shock

Volumn 18, Issue 4, 2002, Pages 301-305

  Emmanuilidis, Klaus ^a   Weighardt, Heike ^a   Matevossian, Edouard ^a   Heidecke, Claus Dieter ^b   Ulm, Kurt ^c   Bartels, Holger ^a   Siewert, Jörg Rüdiger ^a   Holzmann, Bernhard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytokine levels; Mortality risk; Prognostic parameters; Sepsis outcome

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18;

AGED; ARTICLE; BLOOD; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036781109     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200210000-00002     Document Type: Article

References (28)

1. Reinhart K, Karzai W: Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 29:121-125, 2001.
2. Ertel W, Keel M, Neidhardt R, Steckholzer U, Kremer JP, Ungethuem U, Trentz O: Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 89:1612-1620, 1997.
3. Weighardt H, Heidecke CD, Emmanuilidis K, Maier S, Bartels H, Siewert JR, Holzmann B: Sepsis after major visceral surgery is associated with sustained and interferon-γ-resistant defects of monocyte cytokine production. Surgery 127:309-315, 2000.
4. Hensler T, Heidecke CD, Hecker H, Heeg K, Bartels H, Zantl N, Wagner H, Siewert JR, Holzmann B: Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 161:2655-2659, 1998.
5. Weighardt H, Heidecke CD, Westerholt A, Emmanuilidis K, Maier S, Veit M, Gerauer K, Matevossian E, Ulm K, Siewert JR, Holzmann B: Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg 235(4):560-567, 2002.
6. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL: Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437-5443, 1999.
7. Zisman DA, Kunkel SL, Strieter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Standiford TJ: Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs clearance in murine Escherichia coli peritoneal sepsis. Shock 8:349-356, 1997.
8. Zantl N, Uebe A, Neumann B, Wagner H, Siewert JR, Holzmann B, Heidecke CD, Pfeffer K: Essential role of γ-interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun 66:2300-2309, 1998.
9. Goebel A, Kavanagh E, Lyons A, Saporoschetz IB, Soberg C, Lederer JA, Mannick JA, Rodrick ML: Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg 231:253-261, 2000.
10. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2-lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-492, 1995.
11. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH: The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16:495-521, 1998.
12. Lamont AG, Adorini L: IL-12: a key cytokine in immune regulation. Immunol Today 17:214-217, 1996.
13. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995.
14. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M-R, Gorman D, Wagner J, Zurawski S, Liu Y-J, Abrams JS, Moore KW, Rennick D, de Waal Malefyt R, Hannum C, Bazan JF, Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725, 2000.
15. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474, 2001.
16. Dinarello CA: Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11:483-486, 2000.
17. Akira S: The role of IL-18 in innate immunity. Curr Opin Immunol 12:59-63, 2000.
18. Swain SL: Interleukin-18: tipping the balance towards a T helper cell 1 response. J Exp Med 194:F11-F14, 2001.
19. + human blood mononuclear cells. J Clin Invest 101:711-721, 1998.
20. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RMH, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992.
21. Grobmyer SR, Lin E, Lowry SF, Rivadeneira DE, Potter S, Barie PS, Nathan CF: Elevation of IL-18 in human sepsis. J Clin Immunol 20:212-215, 2000.
22. Endo S, Inada K, Yamada Y, Wakabayashi G, Ishikura H, Tanaka T, Sato S: Interleukin-18 (IL-18) levels in patients with sepsis. J Med 31:15-20, 2000.
23. Novick D, Schwartsburd B, Pinkus N, Suissa D, Belzer I, Sthoeger Z, Keane WF, Chvatchko Y, Kim S-H, Fantuzzi G, Dinarello CA, Rubinstein M: A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14:334-342, 2001.
24. Oberholzer A, Harter L, Feilner A, Steckholzer U, Trentz O, Ertel W: Differential effect of caspase inhibition on proinflammatory cytokine release in septic patients. Shock 14:253-257, 2000.
25. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M: Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88-91, 1995.
26. Netea MG, Fantuzzi G, Kullberg BJ, Stuyt RJL, Pulido EJ, McIntyre RC, Joosten LAB, Van der Meer JWM, Dinarello CA: Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol 164:2644-2649, 2000.
27. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A: IGIF does not drive Th1 development but synergizes with IL-12 for Interferon-γ production and activates IRAK and NFκB. Immunity 7:571-581, 1997.
28. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S-I, Okamura H, Akira S, Nakanishi K: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-γ production. J Immunol 161:3400-3407, 1998.